Ovid Therapeutics Inc.【OVID】 業績推移・財務諸表

(単位:千ドル) 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25
売上高 - - - - - - - - - - - - - - 6,914 208,382 - - 1,445 - 11 66 75 108 148 169 173 130
売上成長率(%) - - - - - - - - - - - - - - - - - - - - -
研究開発費 31,284 6,074 5,899 - 8,474 8,116 8,544 - 9,337 9,117 11,597 - 14,625 16,032 15,875 16,248 7,683 4,917 7,832 6,046 5,183 6,614 5,998 5,332 10,397 12,582 7,855 6,659
販売管理費 2,977 - - - - - - - - - - - - - - - - - - - - - - - - - - -
営業費用 34,262 10,288 9,409 11,048 13,429 13,209 13,175 13,116 14,053 13,322 16,765 17,267 20,294 23,141 23,317 31,825 14,312 11,681 17,712 14,304 12,814 14,958 14,246 12,137 17,565 20,686 13,399 12,680
営業利益 - -10,289 -9,410 - -13,430 -13,210 -13,176 - -14,054 -13,323 -16,766 - -20,295 -23,142 -16,404 176,557 -14,313 -11,682 -16,268 -14,305 -12,804 -14,893 -14,172 -12,029 -17,417 -20,517 -13,226 -12,550
営業利益率 (%) - - - - - - - - - - - - - - - - -
経常(税引前)利益 -34,239 - - - - - - - - - - - - - - 176,507 -14,300 -11,700 -16,059 -14,589 -11,968 -13,357 -12,409 -11,253 -11,694 8,521 -14,006 -10,235
経常(税引前)利益率(%) - - - - - - - - - - - - - - - 84.7 - - -1111.0 - -107798.33 -20187.74 -16544.44 -10325.94 -7901.35 5042.01 -8095.95 -7873.08
法人税等合計 0 - - - - - - - - - - - - - - 500 1,500 -300 50 - - - - - - - - -
実効税率(%) - - - - - - - - - - - - - - - - - - - - - - -
純利益 -34,239 -10,249 -9,359 -10,960 -13,183 -12,936 -12,962 -12,900 -13,801 -13,058 -16,635 -16,968 -20,031 -22,552 -16,425 176,007 -15,789 -11,385 -16,109 -14,589 -11,968 -13,357 -12,409 -11,253 -11,694 8,521 -14,006 -10,235
純利益率(%) - - - - - - - - - - - - - - - - -
一株あたり利益 - - - - - - - - - - - - - - - 2.55 -0.23 -0.17 -0.23 -0.21 -0.17 -0.19 -0.18 -0.16 -0.17 0.12 -0.2 -
希薄化後一株あたり利益 - - - - - - - - - - - - - - - 2.53 -0.23 -0.17 -0.23 -0.21 -0.17 -0.19 -0.18 -0.16 -0.17 0.12 -0.2 -
EBITDA - - - - - - - - - - - - - - - - - - - -
EBITDAマージン(%) - - - - - - - - - - - - - - - - - - - - - - -